Skip to content

Intravenous Infusion of Lidocaine in Colonoscopy

Efficacy of Intravenous Infusion of Lidocaine in Sedation for Colonoscopy: a Randomised Placebo-controlled Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04439786
Enrollment
50
Registered
2020-06-19
Start date
2020-07-01
Completion date
2020-12-31
Last updated
2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation

Keywords

intravenous lidocaine coloscopy

Brief summary

intravenous infusion of lidocaine significantly reduce fatigue and pain and improve the patients satisfaction after sedation for colonoscopy.

Detailed description

This study divide patients into two groups, lidocaine group one will be given lidocaine intravenously; control group will be given saline . the difference between patients fatigue and pain will be compared. and the propofol consumption, pain after infusion of propofol, patients, endoscopists and anaesthesist satifaction, the incidence of hypotenstion, hypoxia, and bradycardia will aslo be compared between the two groups.

Interventions

DRUGplacebo

the control group will be given the same volume of saline.

DRUGlidocaine

the experimental group will be given 1-1.5mg/kg lidocaine and then 2mg/kg/h

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

Participants are randomly assigned to controll group or lidocaine group. Participants of control group are given placebo while participants of lidocaine group are given lidocaine.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion Criteria: patients aged \>18 years who were scheduled for colonscopy at Qilu hospital.

Exclusion criteria

patients with ASA (American Society of Anesthesiologists) Class 4 or 5, pre-existing hypoxemia (SpO2 \<90%), hypotension (systolic blood pressure \<90 mm Hg), bradycardia (HR\<50 beats/min), uncontrolled hypertension (SBP \>170 mm Hg, diastolic blood pressure\>100 mm Hg), severe renal or liver failure, pregnancy or lactation, allergy to lidocaine, atrioventricular block, epilepsy, and inability to give informed consen \-

Design outcomes

Primary

MeasureTime frameDescription
fatigue score after colonoscopyhalf a yearfatigue were measured on a 0-10VAS at arrival in the recovery room ,30min later

Secondary

MeasureTime frameDescription
pain socre after colonoscopyhalf a yearpain were measured on a 0-10VAS at arrival in the recovery room ,30min later

Other

MeasureTime frameDescription
Safety assessed by the rate of hypotention during the procedurehalf a yearHypotension, defined as systolic blood pressure \<90 mmHg
Safety assessed by the rate of breadycardia during the procedurehalf a yearBradycardia, defined as heart rate \<50 beats/min
Safety assessed by the rate of required airway management during the procedurehalf a yearRequired airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia Required airway management such as jaw lifting, mask ventilation, or tracheal intubation in severe hypoxia
infusion pain when adminstrate propofolhalf a yearinfusion pain was divided into no pain, mide pain and severe pain
endoscopists satisfaction assessed by the performerhalf a yearthe endoscopists satisfacition score were assessed on a 0-10VAS after the procedure
patient satisfaction assessed by the patienthalf a yearthe patient satisfacition score were assessed on a 0-10VAS 30mins after the procedure
anesthetist satisfaction assessed by the anesthestisthalf a yearthe anesthetist satisfacition score were assessed on a 0-10VAS after the procedure
Safety assessed by the rate of involuntary movementhalf a yearInvoluntary movements, defined as unconscious movements requiring restraint or severe limb movement
Safety assessed by the rate of hypoxia during the procedure Safety assessed by the rate of hypoxia during the procedurehalf a yearHypoxia, defined as peripheral oxygen saturation \<90% for \>10 seconds

Countries

China

Contacts

Primary ContactJing Liu, MD
liujingqilu@126.com+86-18560083755
Backup Contactyanqing li, phD
liyanqing@sdu.edu.cn86-531-82169236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026